The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Gout Therapeutics Global Market Report 2023, the gout therapeutics market is expected to show significant growth in the forecast period.

Key insights from the gout therapeutics market forecast include:

1. Market Size

The global gout therapeutics market is projected to increase from $2.25 billion in 2022 to $2.54 billion in 2023, with a 12.9% CAGR. It is anticipated to reach $3.96 billion in 2027, with an 11.8% CAGR.

2. Major Driver

The gout therapeutics market is poised for growth due to the increasing prevalence of gout. Gout is characterized by painful and swollen joints, and gout therapeutics are used to alleviate these symptoms. For instance, between 2021 and 2022, British hospitals reported 250,000 new cases of gout, marking a 20% increase from the past three years, as per the National Health Service. This rising incidence of gout contributes to the expansion of the gout therapeutics market.

View More On The Gout Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

3. Key Trend

Product innovation is a prominent trend in the gout therapeutics market. Leading companies are introducing innovative treatments to maintain their market standing. For instance, in August 2022, Synlogic Inc. unveiled SYNB2081, a novel gout treatment drug candidate that lowers uric acid. This synthetic biotic is the second clinical drug candidate resulting from a research partnership between Synlogic and Ginkgo, a US-based biotech firm.

4. Largest Region

North America was the largest region in the gout therapeutics market in 2022.

5. Major Players

Major players in the gout therapeutics market are AbbVie Inc., Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., Avion Pharmaceuticals LLC, Protalix BioTherapeutics Inc., Teijin Pharma Limited, Romeg Therapeutics LLC., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., and Shanton Pharma.

Request A Sample Of The Global Gout Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12118&type=smp

Key Gout Therapeutics Market Segments
The global gout therapeutics market is segmented –
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users

The Gout Therapeutics Global Market Report 2023  provides an in-depth analysis on the gout therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the gout therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Pharmaceutical Sterility Testing Global Market Report 2023
Pyrogen Testing Global Market Report 2023
Pharmaceutical Drug Delivery Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model